You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科倫博泰生物-B(06990.HK):上半年收入達10.46億元 同比增長203.3%%
格隆匯 08-28 22:10

格隆匯8月28日丨科倫博泰生物-B(06990.HK)發佈公吿,截至2023年6月30日止六個月,實現收入人民幣10.46億元,同比增長203.3%%;毛利6.76人民幣億元,同比增長199.1%;研發開支達人民幣4.9034億元,同比增長42.6%。報吿期內,集團的研發開支較上年同期增加42.6%,主要由於試驗及測試開支增加;員工成本增加;及其他研發開支增加,如公用事業、維護及維修成本,以及與研發活動有關的知識產權應用及維護的開支。該等增加主要是由於集團對持續研發項目的投資增加所致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account